Similar articles

• The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.

  Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E. Meijer J, et al. Cancer Res. 2008 Jun 15;68(12):4701-8. doi: 10.1158/0008-5472.CAN-08-0482. Cancer Res. 2008. Retraction in: Cancer Res. 2011 Feb 1;71(3):1196. doi: 10.1158/0008-5472.CAN-10-4378. PMID: 18559516 Retracted.
• CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.

  Deng L, Chen N, Li Y, Zheng H, Lei Q. Deng L, et al. Biochim Biophys Acta. 2010 Aug;1806(1):42-9. doi: 10.1016/j.bbcan.2010.01.004. Epub 2010 Feb 1. Biochim Biophys Acta. 2010. PMID: 20122997 Review.
• Site-directed mutagenesis of the chemokine receptor CXCR6 suggests a novel paradigm for interactions with the ligand CXCL16.

  Petit SJ, Chayen NE, Pease JE. Petit SJ, et al. Eur J Immunol. 2008 Aug;38(8):2337-50. doi: 10.1002/eji.200838269. Eur J Immunol. 2008. PMID: 18629940
• Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.

  Tabata S, Kadowaki N, Kitawaki T, Shimaoka T, Yonehara S, Yoshie O, Uchiyama T. Tabata S, et al. J Leukoc Biol. 2005 May;77(5):777-86. doi: 10.1189/jlb.1204733. Epub 2005 Feb 9. J Leukoc Biol. 2005. PMID: 15703197
• Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.

  Yoon MS, Pham CT, Phan MT, Shin DJ, Jang YY, Park MH, Kim SK, Kim S, Cho D. Yoon MS, et al. Cytotherapy. 2016 Dec;18(12):1532-1542. doi: 10.1016/j.jcyt.2016.08.006. Epub 2016 Oct 6. Cytotherapy. 2016. PMID: 27720639